Dexmedetomidine for sedation in procedures outside of surgery rooms

Dexmedetomidina para sedación en procedimientos fuera de salas de cirugía

Invasive procedures outside surgery rooms can imply significant discomfort for the patient and create technical challenges and deterioration in the quality of care. The above has involved anesthesiologists in the care of these patients outside of surgery rooms. The present prospective study evaluated the use of dexmedetomidine, an a2 agonist authorized as a sedative in the intensive care unit, in 27 patients, between 18 and 80 years of age, with classification of anesthetic risk American Society of Anesthesiology I - IV, who underwent radiology, endoscopy and radiotherapy interventions; Dexmedetomidine is a medication that produces an adequate and safe degree of sedation to perform such interventions outside of surgery rooms. A loading dose of the linfkg drug was administered in 10 minutes, continuing with an infusion between 0.2 and 0.8 pg / kg. The results indicate that the programmed procedures could be carried out in their entirety. There were adverse effects such as hypotension and bradycardia in five cases, which were easy to treat. No patient presented respiratory depression and recovery was rapid with high Aldrete scores. The degree of satisfaction of the patients was, in its great majority, excellent to good. This study suggests the use of dexmedetomidine as a good alternative for anesthetic sedation.

Arain SR, Ebert J.The efficacy, side effects, and recovery characteristics of Dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002; 95 (2): 461- 66.

Bustillo M, Lazar R, Finck AD. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: A retrospective case report series. Neurosurg Anesth 2002; 14 (3):209-12.

Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Critic Care 2001; 7(4): 221-6

Elbert T, Hall J, Barney J.The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93: 382-94.

Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic proper of small dose dexmedetomidine infusions. Anesth Analg 2000; 90(3):699-705.

Kamihavashi T, Naze M.Clinical uses of a 2 adrenergic agonists. Anesthesiology 2000; 93:1345-49.

Malberg AB, Hedley LR, Jasper JR. Hunter JC, Basbaum Al. Contribution of alpha (2) receptor subtypes to nerve injuryinduced pain and its regulation by dexmedetomidine. Br J Pharmacol. 2001;132(8): 1827-36.

Mattila MJ, Mattila ME,Olkkola KT Scheinin H. Effec of dexmedetomidine and mida7olam on performance and mood. Eur Clin Pharmaco 1991; 41(3):217-23.

Moerman N, Van Darn FS, Muller MJ, Dosling The Amsterdam preoperative Anxiety an information scale. Anesth Analg 1996. 82:445-51.

S a Rego MM, Watcha MF, White P,Mehernoor E The changing role of monitored anesthesia care in the ambulatory setting. Anesth Analg 1997; 85(5) 1020-36.

Venn RM, Bryant A, Hall GM, Grounds RM. Effects of Desxmedetomidine on adrenocortical function, and the cadiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anesth 2001;86(5) : 650-56.